214 Participants NeededMy employer runs this trial

PRISM Program for Obesity

(PRISM Trial)

MM
Overseen ByMelissa M Crane, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Rush University Medical Center
Must be taking: Liraglutide, Semaglutide, Tirzepatide
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial pilot is to determine the feasibility of an intervention to enhance weight management in patients who have stopped taking anti-obesity/weight management medications in primary care. The main questions it aims to answer are:

* Can patients be recruited into the study efficiently?

* Is the program acceptable to patients?

* Can the study be conducted efficiently?

The new program will be compared to usual care.

Are You a Good Fit for This Trial?

This trial is for adults (18+) with obesity who were prescribed certain weight loss medications by a primary care provider at Rush University and have recently stopped taking them. Participants must have a BMI of 30 or higher, or 27+ with related health issues, including those identifying as Asian.

Inclusion Criteria

I am obese according to my BMI or have obesity-related health issues.
I am willing to stop taking my anti-obesity medication for this study.
I am 18 years old or older.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants in the PRISM Program complete online visits using study-provided scales, video visits with study staff monthly, and online check-ins weekly

6 months
Monthly video visits, weekly online check-ins

Follow-up

Participants are monitored for weight change and adherence to the intervention

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • PRISM Program

Trial Overview

The study is testing the PRISM program—a new support strategy to help people manage their weight after stopping anti-obesity medication—compared to usual care in primary care settings. Participants are randomly assigned to either group.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: PRISM ProgramExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rush University Medical Center

Lead Sponsor

Trials
448
Recruited
247,000+